Skip to main content
. Author manuscript; available in PMC: 2015 Nov 16.
Published in final edited form as: Log J IGPL. 2014 Nov 19;23(2):141–173. doi: 10.1093/jigpal/jzu028

Table 5.

Twenty Top Predicted Therapeutic Relationships for Hormone-refractory Prostate Cancer

rank agent TREATS Active
1 gefitinib
2 paclitaxel
3 gemcitabine
4 resveratrol
5 methotrexate
6 sorafenib
7 tretinoin
8 cyclophosphamide
9 cyclosporine
10 epigallocatechin gallate
11 sirolimus
12 fluorouracil
13 troglitazone
14 dactinomycin
15 estradiol
16 topotecan
17 cycloheximide
18 docetaxel
19 dehydroepiandrosterone
20 celecoxib